We are live on ! Find out more
MDGSW

Medigus Series C Warrant

Delisted

MDGSW was delisted on the 19th of July, 2023.

5 hedge funds and large institutions have $781K invested in Medigus Series C Warrant in 2021 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% less funds holding

Funds holding: 6 → 5 (-1)

100% less capital inflows, than outflows

Capital inflows: $0 | Capital outflows: $67.8K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

MDGSW Hedge Fund Activity: Q2 2021 in Review

5 of the 5,768 institutional investors tracked by Wall St. Rank reported a position in Medigus Series C Warrant (MDGSW) for Q2 2021, worth a combined $781K — down 40% from $1.3M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of MDGSW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.

The largest seller was Equitec Specialists, exiting entirely with an estimated $65K sold.

  • 5 institutional investors held Medigus Series C Warrant (MDGSW) as of Q2 2021, down from 6 in Q1 2021.
  • Funds reported $781K of Medigus Series C Warrant stock for Q2 2021, down 40% quarter-over-quarter.
  • 0 funds opened new Medigus Series C Warrant positions in Q2 2021 and 1 closed out, a net change of -1 holder.
  • The largest Medigus Series C Warrant seller in Q2 2021 was Equitec Specialists, an estimated $65K sold.

Based on aggregated 13F filings for Q2 2021.